Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation reports developments tied to its role as a diversified healthcare services company and major pharmaceutical distributor. Company news commonly covers fiscal results and guidance, dividend declarations, capital allocation, share repurchase activity, and updates across core distribution, oncology and multispecialty, biopharma services, pharmacy technology, and medical-surgical product categories.
McKesson updates also include portfolio actions and governance changes. Recent company materials document the completed divestiture of its Norwegian retail and distribution businesses, marking its exit from European operations, alongside recurring communications about earnings events, healthcare conferences, and leadership succession matters.
Summary not available.
McKesson (NYSE: MCK) has completed its acquisition of a controlling interest in PRISM Vision Holdings, a leading provider of ophthalmology and retina management services. The transaction values at approximately $850 million for an 80% stake, while PRISM physicians retain the remaining 20% interest.
The strategic acquisition aims to establish McKesson as a leading platform in retinal and ophthalmology services, enhancing its differentiated value proposition, clinical services, and distribution offerings. The company also announced it will release its fourth quarter and full year fiscal 2025 financial results after market close on May 8, 2025, followed by an earnings conference call at 4:30 PM Eastern Time.
McKesson (NYSE: MCK) has announced its financial results for the third quarter of fiscal year 2025. The company has also raised its full-year adjusted EPS guidance. The detailed financial results are available on McKesson's Investor Relations website. The company is hosting a live webcast earnings conference call on February 5th at 4:30 PM ET to discuss the results with investors. The webcast, earnings release, financial tables, and presentation slides will be accessible on McKesson's Investor Relations platform.
McKesson (NYSE: MCK) has announced a definitive agreement to acquire an 80% controlling interest in PRISM Vision Holdings for approximately $850 million. PRISM Vision physicians will retain the remaining 20% interest. PRISM Vision is a premier provider of general ophthalmology and retina management services, operating with more than 180 providers across 91 office locations and seven ambulatory surgery centers.
The acquisition will be consolidated within McKesson's U.S. Pharmaceutical segment and is expected to be $0.20 to $0.30 accretive to McKesson's Adjusted Earnings Per Diluted Share in the first 12 months, growing to $0.65 to $0.75 by the end of the third year. The transaction aims to strengthen McKesson's position in retina and ophthalmology care, expand data and analytics capabilities, and enhance clinical research opportunities.
McKesson (NYSE:MCK) has announced its Board of Directors has declared a quarterly dividend of $0.71 per share of common stock. The dividend will be distributed to shareholders of record as of March 3, 2025, with the payment scheduled for April 1, 2025.
McKesson (NYSE: MCK) has successfully completed the divestiture of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm, on December 30, 2024. The transaction, which was initially announced in September 2024, aligns with McKesson's strategic focus on capital deployment and prioritization of investments in expanding its oncology and biopharma growth platforms.
McKesson (NYSE: MCK) will release its third quarter fiscal 2025 financial results after market close on Wednesday, February 5, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will be participating in the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. The live webcast for each event will be available on McKesson’s Investor Relations website at http://investor.mckesson.com, along with the company’s earnings release, financial tables and slide presentation.